Growth Metrics

Sanara MedTech (SMTI) Liabilities and Shareholders Equity (2016 - 2025)

Sanara MedTech's Liabilities and Shareholders Equity history spans 15 years, with the latest figure at $72.9 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 17.2% year-over-year to $72.9 million; the TTM value through Dec 2025 reached $339.2 million, up 5.69%, while the annual FY2025 figure was $72.9 million, 17.2% down from the prior year.
  • Liabilities and Shareholders Equity reached $72.9 million in Q4 2025 per SMTI's latest filing, up from $71.1 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $98.8 million in Q2 2025 to a low of $33.9 million in Q1 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $64.8 million, with a median of $71.0 million recorded in 2024.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 309.64% in 2021, then dropped 19.72% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $36.4 million in 2021, then soared by 67.7% to $61.0 million in 2022, then increased by 21.03% to $73.9 million in 2023, then grew by 19.25% to $88.1 million in 2024, then decreased by 17.2% to $72.9 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Liabilities and Shareholders Equity are $72.9 million (Q4 2025), $71.1 million (Q3 2025), and $98.8 million (Q2 2025).